Plan sponsors looking to integrate pharmacogenetic testing into their benefits plan will soon have lots of information to consider as Canada’s biggest insurance companies roll out pilot projects and research begins to shed light on the return on investment. “The market is expanding. Insurers are piloting projects. You will hear a lot about pharmacogenetics over the next 12 months,” said […]
Like many Canadians, I’ve witnessed first-hand the struggles people experience in obtaining a timely, affordable appointment with a mental-health professional. Loved ones often face lengthy wait times and disjointed care, while family members try to help as best they can. With one in five Canadians experiencing a mental-health problem or illness in any given year, […]
While medications to treat mental illness are a major source of drug spending, that money may be going to waste if patients don’t take their drugs as prescribed. Presenting at the recent Mental Health Summit Vancouver, Allison Nourse, national director of pharmacy innovation at Pharmasave Drugs Ltd., explored the ways community pharmacists can optimize medications […]
As innovations in science and technology disrupt the status quo, developments such as pharmacogenetic testing in group benefits plans and robo-advisors in the pension industry are offering new options for plan members, a panel of experts said at an event on Wednesday. The acceptance of pharmacogenetic testing is growing as 88 per cent of doctors believe it will be the […]